Maven Securities’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-21,275
Closed -$1M 1175
2021
Q1
$1M Sell
21,275
-23,136
-52% -$1.26M 0.05% 413
2020
Q4
$2.09M Buy
+44,411
New +$1.75M 0.21% 122

Other funds holding NBP

Maven Securities's NBP Position: Q2 2021 in Review

Maven Securities sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q2 2021, closing a stake of 21,275 shares — an estimated $1M sold.

Maven Securities first reported a position in NBP in Q4 2020 and held it in 2 quarters. The position peaked at $2.09M in Q4 2020. 136 funds tracked by Wall St. Rank hold NBP as of Q2 2021.

  • Maven Securities reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • Maven Securities sold 21,275 NovaBridge Biosciences American Depositary Shares shares in Q2 2021, an estimated $1M.
  • Maven Securities first reported a position in NovaBridge Biosciences American Depositary Shares in Q4 2020 and held it in 2 quarters.
  • Maven Securities's NovaBridge Biosciences American Depositary Shares position peaked at $2.09M in Q4 2020.
  • 136 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2021.

Based on Maven Securities's 13F filing for Q2 2021, filed 16 Aug 2021.